Research Keyword: Aspergillus fumigatus

RttA, a Zn2-Cys6 transcription factor in Aspergillus fumigatus, contributes to azole resistance

Researchers discovered that a fungal protein called RttA plays a key role in helping Aspergillus fumigatus resist azole antifungal drugs. By studying mutant strains, they found that RttA acts as a master switch controlling genes that reduce the effectiveness of antifungal medications. This finding is important because it could help develop new strategies to treat fungal infections that are becoming resistant to current medications.

Read More »

An Atypical Presentation of Allergic Bronchopulmonary Aspergillosis

A 57-year-old man without prior lung problems developed a persistent cough and breathing difficulties that didn’t respond to antibiotics. Imaging showed his lung had collapsed and fluid had accumulated around it, raising concerns about cancer. However, bronchoscopy revealed the collapse was caused by thick mucus plugs filled with Aspergillus fungus rather than cancer. After treatment with antifungal medication and steroids, the patient fully recovered with his lung re-expanding and fluid resolving.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, especially in patients whose immune systems are weakened. The researchers found that while most hospitals have good access to testing and antifungal medications, some important tests are still missing, and many hospitals send samples to other facilities for testing, which can delay treatment. Since this region has unusually high rates of fungal infections that resist common antifungal drugs, improving access to advanced diagnostic tests is crucial for patient survival.

Read More »

Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth

This study examines how Trikafta, a new cystic fibrosis medication, affects a common fungal lung infection (Aspergillus fumigatus). The researchers found that Trikafta doesn’t directly kill the fungus but does make it more susceptible to antifungal drugs and improves lung clearance. Surprisingly, at high concentrations, the medication actually reduced the immune response against the fungus in immune cells, suggesting the need for careful monitoring of patients on this therapy.

Read More »

The C-type lectin receptor Dcir (Clec4a2) restrains Aspergillus fumigatus elimination by limiting the degranulatory activity of neutrophils

This study reveals that a receptor called Dcir on immune cells called neutrophils actually prevents effective killing of the fungus Aspergillus fumigatus by limiting the release of antibacterial granules. When researchers removed Dcir from mice, their neutrophils became more effective at fighting the fungal infection. This suggests that blocking Dcir might help patients with fungal respiratory infections clear the pathogen more effectively.

Read More »

Acute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report

An 87-year-old man with COVID-19 developed a rare and severe fungal infection in his airways caused by Aspergillus fumigatus. Doctors used a camera tube (bronchoscope) to see thick, yellowish-white membrane-like material coating his entire windpipe and airways, which is an extremely rare complication. Despite starting antifungal medications, his condition rapidly worsened leading to organ failure and death. This case highlights how COVID-19 can leave patients vulnerable to serious secondary fungal infections that require immediate recognition and treatment.

Read More »

Genome sequences of Aspergillus fumigatus strains isolated from wildfowl in Southern Ontario, Canada

Researchers sequenced the genomes of four Aspergillus fumigatus fungi isolated from infected birds (an osprey, peregrine falcon, and two hawks) brought to wildlife rehabilitation centers in Ontario. This fungus causes a serious infection called aspergillosis that damages the lungs and air sacs of birds. The genetic information from these four strains is now publicly available for scientists studying how this fungus infects birds and how it resists antifungal treatments.

Read More »

In Vitro Activity of Nitroxoline (5-Nitro-8-Hydroxyquinoline) Against Aspergillus Species

Researchers tested an old antibiotic called nitroxoline against Aspergillus fungi that cause serious infections in immunocompromised patients. The drug works by removing zinc that the fungus needs to survive. The study found that nitroxoline was very effective against all tested fungal strains, including those resistant to modern antifungal drugs, suggesting it could potentially be repurposed as a new treatment option.

Read More »

Moving beyond multi-triazole to multi-fungicide resistance: Broader selection of drug resistance in the human fungal pathogen Aspergillus fumigatus

Aspergillus fumigatus is a dangerous fungal infection treated with triazole drugs, but the fungus is developing resistance to multiple antifungal medications. This resistance appears to be selected in agricultural settings where fungicides are used on crops, and resistant strains then spread to humans through the air. The problem is worse because agricultural fungicides are selecting for strains resistant to multiple drug classes at once, making infections harder to treat. Addressing this issue requires reducing fungicide use in agriculture and better strategies for managing antifungal resistance.

Read More »
Scroll to Top